CellPly

Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.

Oraigo is a leading company in the development of innovative road safety technology, utilizing brain-computer interface technology, mobile and web applications, and advanced statistical models. Their flagship product, AiGo, uses EEG technology to detect drowsiness and microsleep events, providing critical interventions to prevent accidents. Oraigo's solutions are especially beneficial for professional drivers, offering practicality, efficacy, and ease of use. By providing these technologies through a SaaS model to trucking companies, Oraigo improves road safety and driver well-being.

FTnet is a digital platform in the pharmaceutical industry that employs advanced technology to connect pharmaceutical companies and pharmacies. Its main objective is to streamline the exchange of commercial information and related activities by digitalizing them. The ultimate goal is to facilitate direct and knowledgeable interactions between industry stakeholders and retailers to foster mutually beneficial value exchanges.

Genoa Instruments is a cutting-edge startup focused on revolutionizing biomedical and health research using advanced super-resolution optical microscopy. Our innovative microscope combines spatial and temporal super-resolution to provide incredibly detailed imaging of living samples. We strive to democratize high-resolution imaging for all, promoting scientific breakthroughs and progressing healthcare research.

Resalis Therapeutics is focusing on addressing metabolic diseases by targeting a key regulator linked to obesity and fatty liver disease. The company is using its expertise in non-coding RNA drugs and lipid metabolism to develop a treatment called RES-010, which aims to provide effective weight loss and reduce liver fat. With promising preclinical results, Resalis plans to quickly move RES-010 into clinical trials for various metabolic disorders.

CoRe is an Italian start-up, aimed at the study of new product and process solutions in the field of composite materials. In 2015, CoRe developed and patented an innovative composite sandwich called the MadFlex and started to introduced it to the market. Thanks to a weight and an environmental impact 4 times lower than ABS and aluminium and to its unique mechanical properties, the MadFlex allows rethinking, redesigning and simplifying a considerable number of applications in different fields, from automotive/nautical to building /furnishing, from aerospace/defence to sport /healthcare. In a fast growing global economy, weight, encumbrance, environmental impact and modularity are key concepts. At present however, companies must choose between structural strength/insulation efficiency and lightweight/transportability. Often, the wished result is achieved only by the use of complex systems (hinges) and additional material layers, with consequent increased costs and labour. In developing the MadFlex, CoRe wanted to give companies the opportunity not to choose, but to have all they needed in a single, highly performing product. MadFlex social impact can be summarized into 4 main pillars: 1. Improved logistics: 9m MadFlex rollable in 20 cm. No need for exceptional transport and reduction of encumbrances for shipments. 2. New building solutions: green, anti-seismic and with a futuristic aesthetic finish 3. Sustainable mobility: Reduced weight, fuel consumption and environmental impact 4. Freedom of movement: Safe and highly performing orthopaedic devices. In 2016, CoRe won the Start-up Booster call promoted European Institute of Technology – Raw Materials, that recognized the innovative contribution of the MadFlex.

Established in 1999, PHSE is a leading provider of time-sensitive and temperature-controlled transport services for the pharmaceutical, biotech, and life sciences industries. The company specializes in healthcare logistics and manages global shipments of various medical products by air, land, and sea at specific temperature requirements. In 2020, PHSE expanded its international presence through the acquisition of five companies, including TEK Freight, Rapida Time and Temperature, Duimex, Bio Transportes, and Air Plus.

NOUS is a biotech startup working on developing a new era of ingredients for Food&Beverage and Nutraceutical Market. Our first product is Mindave, a caffeine alternative that enhances cognitive and physical performance, improving memory, concentration and reflexes without causing the typical adverse effects of caffeine such as blood pressure spikes or tachycardia, and improves gastrointestinal well-being. A recent functional study demonstrated the effectiveness of Mindave on cognitive function, showing benefits even superior to caffeine. Worldwide, 709 million people should avoid caffeine due to gastrointestinal or heart problems. However, there is currently no viable, healthy and 100% natural alternative on the market to enable everyone to face each day with full energy. In addition, the rapid changes in consumer needs and market trends pose a major challenge to medium and large companies who are unable to respond quickly to the constant new product launches. We are targeting companies with a clear health mission, enabling us to help consumers live better. Our ideal customers are beverage and food companies for developing new functional products, ingredient companies for exponential distribution through consolidated networks, and fitness companies. Being selected for the Plag&Play accelerator programme in San Francisco has opened the door to the American market and after filling the international patent in December 2023, we started the commercialisation in January 2024. To date we have +11 LOIs from customers, 5 POCs underway with ITA and US companies, 1 contract for product development consultancy with a startup and 1 ingredient company selling Mindave as part of their portfolio, allowing us to benefit from their network. We are firm believers in the link between human health and the environment’s health. With Mindave, we estimate -40% of water waste, -30% of deforestation and -30% of CO2 emissions at full production compared to coffee farming. Our focus on sustainable innovation leads us to develop new by-products from upcycling every year until we reach zero waste by 2027. We forecast the development of at least 5 products by 2027. Inspired by nature, we aim to innovate the F&B sector while reducing environmental impact.

MOGU, an Italian-based European company, is dedicated to developing a variety of mycelium-based technologies for producing a collection of environmentally friendly and groundbreaking products for interior design. Guided by the principles of the Circular Economy, Mogu firmly believes in harnessing the intelligence of nature to revolutionize the design of common items, establishing a harmonious equilibrium between human-made creations and the patterns of the natural world.

A biotech business called DIAMANTE (Nano-Technologies for Autoimmune Disease) is dedicated to using plants to create compounds with significant added value. The business received funding in 2016 to research novel diagnostic tools for autoimmune diseases, and as we move closer to therapeutic applications, The development of novel therapeutic approaches for autoimmune illnesses based on the restoration of self-tolerance using plant viruses exhibiting immunodominant peptides is our company's value proposition as a female-run business that values innovation. Diamante has made significant advancements in the field of Rheumatoid Arthritis diagnosis thanks to the Regione Veneto and in particular the national grant POR FESR AZIONE 111 2020/2021. (RA)

Relicta developed a water-soluble, transparent and biodegradable plastic for packaging made from fish industrial waste. The project aims to reduce pollution from traditional plastics that are poisoning our oceans, meanwhile adding value to fish waste. It is a circular economy business model: our product will be obtained from a secondary raw material and will not pollute once melted in water.